These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33633029)

  • 1. Challenges in the Management of Childhood Intracranial Germ Cell Tumors in Middle-Income Countries: A 20-Year Retrospective Review From a Single Tertiary Center in Malaysia.
    Rajagopal R; Leong SH; Jawin V; Foo JC; Ahmad Bahuri NF; Mun KS; Azman RR; Loh J; Yap TY; Ariffin H; Moreira DC; Gottardo NG; Bouffet E; Ganesan D
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e913-e923. PubMed ID: 33633029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapsing intracranial germ cell tumours warrant retreatment.
    Callec L; Lardy-Cleaud A; Guerrini-Rousseau L; Alapetite C; Vignon L; Chastagner P; Frappaz D; Faure-Conter C
    Eur J Cancer; 2020 Sep; 136():186-194. PubMed ID: 32711377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
    Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
    Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
    Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
    Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial germ cell tumors: a single-institution experience.
    Khafaga Y; El Weshi A; Nazmy M; Hassounah M; Alshail E; Moussa E; Allam A; Alkofide A; Jamshed A; ELhusseiny G; Ezzat I; Jenkin D
    Ann Saudi Med; 2012; 32(4):359-65. PubMed ID: 22705605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary intracranial germ cell tumors in children 36-year experience of a single center.
    Kurucu N; Akyüz C; Varan A; Zorlu F; Aydin B; Söylemezoglu F; Yalcin B; Kutluk T; Büyükpamukcus M
    J Cancer Res Ther; 2020; 16(6):1459-1465. PubMed ID: 33342813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of pediatric patients with autism spectrum disorder and other neurodevelopmental disorders and intracranial germ cell tumors.
    Liu KX; Sethi RV; Pulsifer MB; D'Gama AM; LaVally B; Ebb DH; Tarbell NJ; Yock TI; MacDonald SM
    Pediatr Blood Cancer; 2021 Aug; 68(8):e28935. PubMed ID: 33694260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
    Lai IC; Wong TT; Shiau CY; Hu YW; Ho DM; Chang KP; Guo WY; Chang FC; Liang ML; Lee YY; Chen HH; Yen SH; Chen YW
    Childs Nerv Syst; 2015 May; 31(5):683-91. PubMed ID: 25749900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.
    Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S
    Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors.
    Huang X; Zhang R; Mao Y; Zhou LF; Zhang C
    World J Pediatr; 2016 Aug; 12(3):275-282. PubMed ID: 27351562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
    Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
    Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term toxicity of intracranial germ cell tumor treatment in adolescents and young adults.
    Wong J; Goddard K; Laperriere N; Dang J; Bouffet E; Bartels U; Hodgson D; Tyldesley S; Hukin J; Cheng S; Bedard PL; Lo AC
    J Neurooncol; 2020 Sep; 149(3):523-532. PubMed ID: 33034840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience.
    Alapetite C; Brisse H; Patte C; Raquin MA; Gaboriaud G; Carrie C; Habrand JL; Thiesse P; Cuilliere JC; Bernier V; Ben-Hassel M; Frappaz D; Baranzelli MC; Bouffet E
    Neuro Oncol; 2010 Dec; 12(12):1318-25. PubMed ID: 20716594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS Mutation in Pediatric Intracranial Germ Cell Tumors.
    Khaiman C; Techavichit P; Poparn H; Chiangthong K; Lauhasurayotin S; Sosothikul D; Shotelersuk K; Nantavithya C; Jakchairoongruang K; Amornfa J; Khongkhaduead E; Santisukwongchote S; Teerapakpinyo C; Shuangshot S
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):3179-3185. PubMed ID: 36172682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial Germ Cell Tumors in Adolescents and Young Adults: A 40-Year Multi-Institutional Review of Outcomes.
    Lo AC; Hodgson D; Dang J; Tyldesley S; Bouffet E; Bartels U; Cheng S; Hukin J; Bedard PL; Goddard K; Laperriere N
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):269-278. PubMed ID: 31654785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
    Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis.
    Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Ariga H; Takai Y; Tominaga T
    J Neurosurg Pediatr; 2009 Dec; 4(6):506-14. PubMed ID: 19951035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications.
    Aizer AA; Sethi RV; Hedley-Whyte ET; Ebb D; Tarbell NJ; Yock TI; Macdonald SM
    Neuro Oncol; 2013 Jul; 15(7):955-60. PubMed ID: 23640532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
    Odagiri K; Omura M; Hata M; Aida N; Niwa T; Ogino I; Kigasawa H; Ito S; Adachi M; Inoue T
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):632-8. PubMed ID: 22420962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.